Brexucabtagene Autoleucel ZUMA-2 and ZUMA-18, Expanded Access Study [ASH 2023] Other 2 Mins Read163 In the realm of advancements in CAR T-cell therapy for relapsed/refractory mantle cell lymphoma (MCL), Dr. Brian Hill, MD, PhD,…
